title: Insulin resistance and management of the menopause: a clinical hypothesis in practice.
abstract: Insulin resistance (IR) is associated with a number of metabolic abnormalities including glucose intolerance, dyslipidemia and central obesity (the metabolic syndrome), which predispose to cardiovascular disease, diabetes mellitus and some cancers. The incidence of many of these conditions increases after the menopause, a time when IR also increases. Medical intervention to help alleviate menopausal symptoms, frequently vasomotor in origin, usually involves hormone replacement therapy (HRT), but some women may only experience partial symptom relief. We have hypothesized that this may be due to concurrent IR. Our approach is therefore to manage menopausal symptoms in conjunction with the treatment of any concurrent IR, achieved through a combination of hormone replacement, dietary intervention and, if necessary, an insulin sensitizer. We suggest that this approach may not only improve symptom relief but may also reduce the risk of developing more serious health complaints in the future.
authors.affiliation: The Surrey Park Clinic, Stirling House, Stirling Road, Guildford, Surrey GU2 7RF, UK. sovra.whitcroft@thesurreyparkclinic.co.uk
authors.forename: Sovra
authors.initials: S
authors.lastname: Whitcroft
authors.forename: Anne
authors.initials: A
authors.lastname: Herriot
mesh_terms: D000368:Aged; D003327:Coronary Disease / Q000378:metabolism / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000378:metabolism / Q000517:prevention & control; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008593:Menopause / Q000378:metabolism*; D008875:Middle Aged; D009765:Obesity / Q000378:metabolism / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000378:metabolism* / Q000517:prevention & control*; D012307:Risk Factors